Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

Black Diamond Therapeutics (BDTX) Return on Capital Employed (2020 - 2025)

Black Diamond Therapeutics (BDTX) has disclosed Return on Capital Employed for 2 consecutive years, with 0.49% as the latest value for Q3 2021.

  • For the quarter ending Q3 2021, Return on Capital Employed fell 32.0% year-over-year to 0.49%, compared with a TTM value of 0.49% through Sep 2021, down 32.0%, and an annual FY2020 reading of 0.3%, changed N/A over the prior year.
  • Return on Capital Employed was 0.49% for Q3 2021 at Black Diamond Therapeutics, down from 0.39% in the prior quarter.
  • Across five years, Return on Capital Employed topped out at 0.13% in Q2 2020 and bottomed at 0.49% in Q3 2021.